KOD
Price
$9.21
Change
-$0.12 (-1.29%)
Updated
Sep 17 closing price
Capitalization
492.83M
55 days until earnings call
NUVB
Price
$3.26
Change
-$0.01 (-0.31%)
Updated
Sep 17 closing price
Capitalization
1.12B
48 days until earnings call
Interact to see
Advertisement

KOD vs NUVB

Header iconKOD vs NUVB Comparison
Open Charts KOD vs NUVBBanner chart's image
Kodiak Sciences
Price$9.21
Change-$0.12 (-1.29%)
Volume$228.67K
Capitalization492.83M
Nuvation Bio
Price$3.26
Change-$0.01 (-0.31%)
Volume$4.95M
Capitalization1.12B
KOD vs NUVB Comparison Chart in %
Loading...
KOD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KOD vs. NUVB commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KOD is a Hold and NUVB is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 18, 2025
Stock price -- (KOD: $9.21 vs. NUVB: $3.26)
Brand notoriety: KOD and NUVB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KOD: 37% vs. NUVB: 90%
Market capitalization -- KOD: $492.83M vs. NUVB: $1.12B
KOD [@Biotechnology] is valued at $492.83M. NUVB’s [@Biotechnology] market capitalization is $1.12B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.34B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KOD’s FA Score shows that 0 FA rating(s) are green whileNUVB’s FA Score has 0 green FA rating(s).

  • KOD’s FA Score: 0 green, 5 red.
  • NUVB’s FA Score: 0 green, 5 red.
According to our system of comparison, both KOD and NUVB are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KOD’s TA Score shows that 4 TA indicator(s) are bullish while NUVB’s TA Score has 5 bullish TA indicator(s).

  • KOD’s TA Score: 4 bullish, 5 bearish.
  • NUVB’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, NUVB is a better buy in the short-term than KOD.

Price Growth

KOD (@Biotechnology) experienced а -5.30% price change this week, while NUVB (@Biotechnology) price change was -1.81% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.28%. For the same industry, the average monthly price growth was +6.08%, and the average quarterly price growth was +34.58%.

Reported Earning Dates

KOD is expected to report earnings on Nov 12, 2025.

NUVB is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+1.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NUVB($1.12B) has a higher market cap than KOD($493M). NUVB YTD gains are higher at: 22.556 vs. KOD (-7.437). KOD has higher annual earnings (EBITDA): -170.11M vs. NUVB (-201.17M). NUVB has more cash in the bank: 608M vs. KOD (104M). NUVB has less debt than KOD: NUVB (57.8M) vs KOD (65.2M). NUVB has higher revenues than KOD: NUVB (14.4M) vs KOD (0).
KODNUVBKOD / NUVB
Capitalization493M1.12B44%
EBITDA-170.11M-201.17M85%
Gain YTD-7.43722.556-33%
P/E RatioN/AN/A-
Revenue014.4M-
Total Cash104M608M17%
Total Debt65.2M57.8M113%
FUNDAMENTALS RATINGS
KOD: Fundamental Ratings
KOD
OUTLOOK RATING
1..100
75
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KODNUVB
RSI
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 3 days ago
82%
MACD
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 27 days ago
86%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 8 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 1 day ago
87%
Aroon
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
KOD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GGEZX29.44N/A
N/A
GuideStone Funds Growth Equity Investor
MAPPX28.09N/A
N/A
Morgan Stanley Inst Advantage A
ZSCCX32.83N/A
N/A
Zacks Small-Cap Core Inv
LGLOX60.61N/A
N/A
Lord Abbett Growth Leaders F3
HFEIX57.57-0.28
-0.48%
Janus Henderson European Focus I

KOD and

Correlation & Price change

A.I.dvisor indicates that over the last year, KOD has been loosely correlated with XNCR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if KOD jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KOD
1D Price
Change %
KOD100%
-1.29%
XNCR - KOD
49%
Loosely correlated
+7.31%
MGNX - KOD
45%
Loosely correlated
+4.08%
IDYA - KOD
45%
Loosely correlated
-1.13%
NRIX - KOD
43%
Loosely correlated
+1.54%
BEAM - KOD
43%
Loosely correlated
-1.86%
More

NUVB and

Correlation & Price change

A.I.dvisor indicates that over the last year, NUVB has been loosely correlated with BEAM. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if NUVB jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUVB
1D Price
Change %
NUVB100%
-0.31%
BEAM - NUVB
49%
Loosely correlated
-1.86%
XNCR - NUVB
48%
Loosely correlated
+7.31%
RCUS - NUVB
47%
Loosely correlated
+2.38%
DNLI - NUVB
46%
Loosely correlated
-1.51%
IDYA - NUVB
46%
Loosely correlated
-1.13%
More